Michael Smith's most recent trade in Lamb Weston Holdings Inc was a trade of 2,211 Common Stock done at an average price of $53.2 . Disclosure was reported to the exchange on Aug. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lamb Weston Holdings Inc | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.16 per share. | 05 Aug 2025 | 2,211 | 109,389 (0%) | 0% | 53.2 | 117,537 | Common Stock |
| Lamb Weston Holdings Inc | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.46 per share. | 29 Jul 2025 | 718 | 111,601 (0%) | 0% | 59.5 | 42,692 | Common Stock |
| Teledyne Technologies Inc | Michael T. Smith | Director | Sale of securities on an exchange or to another person at price $ 560.10 per share. | 28 Jul 2025 | 1,975 | 51,328 (0%) | 0% | 560.1 | 1,106,198 | Common Stock |
| Lamb Weston Holdings Inc | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 72,447 | 72,447 | - | - | Employee Stock Option (Right to Buy) | |
| Lamb Weston Holdings Inc | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 34,505 | 112,319 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston Holdings Inc | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 10,687 | 82,289 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston Holdings Inc | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.79 per share. | 15 Jul 2025 | 4,475 | 77,814 (0%) | 0% | 49.8 | 222,810 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 102.51 per share. | 11 Jul 2025 | 933 | 66,394 (0%) | 0% | 102.5 | 95,642 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 96.41 per share. | 11 Jul 2025 | 748 | 67,327 (0%) | 0% | 96.4 | 72,115 | Common Stock |
| Church Dwight Co Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 1,248 | 1,790 | - | - | Phantom Stock | |
| Ulta Beauty | Michael C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 383 | 2,763 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 73.50 per share. | 05 Jun 2025 | 1,879 | 67,718 (0%) | 0% | 73.5 | 138,107 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 03 Jun 2025 | 1,448 | 69,597 (0%) | 0% | 71.5 | 103,532 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 30 May 2025 | 20,000 | 71,045 (0%) | 0% | 70 | 1,400,000 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 68.56 per share. | 30 May 2025 | 6,327 | 91,045 (0%) | 0% | 68.6 | 433,779 | Common Stock |
| Massimo Group | Michael Smith | Former Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 50,000 | - | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 27,100 | 27,100 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,578 | 97,372 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 67.81 per share. | 13 May 2025 | 4,407 | 92,203 (0%) | 0% | 67.8 | 298,839 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 65.61 per share. | 13 May 2025 | 409 | 91,794 (0%) | 0% | 65.6 | 26,834 | Common Stock |
| Zebra Tech | Michael A. Smith | Director | Grant, award, or other acquisition of securities at price $ 265.37 per share. | 08 May 2025 | 830 | 10,695 (0%) | 0% | 265.4 | 220,257 | Class A Common Stock |
| Church Dwight Co Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 2,890 | 2,890 | - | - | Stock Option (right to buy) | |
| Church Dwight Co Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 860 | 860 (0%) | 0% | 0 | Common Stock | |
| Teledyne Technologies Inc | Michael T. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 468 | 53,303 (0%) | 0% | 0 | Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 4,848 | 4,848 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,744 | 17,875 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,744 | 3,488 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,375 | 19,451 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,375 | 1,375 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,039 | 18,389 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,039 | 0 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.73 per share. | 07 Mar 2025 | 525 | 17,350 (0%) | 0% | 46.7 | 24,533 | V2X, Inc. Common Stock |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.65 per share. | 07 Mar 2025 | 414 | 19,037 (0%) | 0% | 46.6 | 19,313 | V2X, Inc. Common Stock |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.65 per share. | 07 Mar 2025 | 313 | 18,076 (0%) | 0% | 46.6 | 14,601 | V2X, Inc. Common Stock |
| McCormick Co Inc Ordinary | Michael R. Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.96 per share. | 18 Feb 2025 | 9,964 | 120,498 (1%) | 0% | 77.0 | 766,829 | Common Stock - Voting |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 47,295 | 117,260 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 80.90 per share. | 05 Feb 2025 | 20,650 | 96,610 (0%) | 0% | 80.9 | 1,670,585 | Common Stock |
| McCormick Co Inc Ordinary | Michael R. Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,764 | 130,462 (1%) | 0% | 0 | Common Stock - Voting | |
| Teledyne Technologies Inc | Michael T. Smith | Director | Sale of securities on an exchange or to another person at price $ 510.50 per share. | 27 Jan 2025 | 2,100 | 52,835 (0%) | 0% | 510.5 | 1,072,050 | Common Stock |
| MillerKnoll Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 9,905 | 9,905 | - | - | Non-Qualified Stock Option (right to buy) | |
| MillerKnoll Inc | Michael C. Smith | Director | Grant, award, or other acquisition of securities at price $ 21.90 per share. | 15 Jan 2025 | 5,936 | 30,810 (0%) | 0% | 21.9 | 129,998 | Common Stock |
| MillerKnoll Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 3,835 | 19,756 | - | - | Phantom Stock | |
| MillerKnoll Inc | Michael R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 508 | 19,247 | - | - | Phantom Stock | |
| MillerKnoll Inc | Michael R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.91 per share. | 15 Jan 2025 | 508 | 1,793 (0%) | 0% | 21.9 | 11,132 | Common Stock |
| McCormick Co Inc Ordinary | Smith Michael R. | Executive Vice President | 20 Dec 2024 | 2,325 | 232 (0%) | 0% | - | Common Stock - Non Voting | ||
| Teledyne Technologies Inc | Michael T. Smith | Director | Sale of securities on an exchange or to another person at price $ 478.25 per share. | 12 Dec 2024 | 2,025 | 54,935 (0%) | 0% | 478.2 | 968,456 | Common Stock |
| McCormick Co Inc Ordinary | Smith R. Michael | Executive Vice President | 02 Dec 2024 | 1,479 | 1,479 | - | - | Restricted Stock Units | ||
| Church Dwight Co Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 539 | 539 | - | - | Phantom Stock | |
| Massimo Group | Michael Smith | Vice President | 22 Nov 2024 | 25,000 | 25,000 | - | 0 | Common Stock | ||
| McCormick Co Inc Ordinary | Michael R. Smith | Executive VP & CFO | 15 Nov 2024 | 2,350 | 109,698 (1%) | 0% | - | Common Stock - Voting | ||
| McCormick Co Inc Ordinary | Michael R. Smith | Executive VP & CFO | 15 Nov 2024 | 2,350 | 2,557 (0%) | 0% | - | Common Stock - Non Voting | ||
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 74.16 per share. | 13 Sep 2024 | 18,871 | 76,856 (0%) | 0% | 74.2 | 1,399,473 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 74.75 per share. | 13 Sep 2024 | 9,000 | 67,856 (0%) | 0% | 74.8 | 672,750 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.76 per share. | 13 Sep 2024 | 7,000 | 95,727 (0%) | 0% | 22.8 | 159,320 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 7,000 | 0 | - | - | Stock Option (right to buy) | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Purchase of securities on an exchange or from another person at price $ 48.00 per share. | 06 Sep 2024 | 416 | 16,131 (0%) | 0% | 48 | 19,968 | V2X, Inc. Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 72.75 per share. | 12 Aug 2024 | 67,655 | 109,142 (0%) | 0% | 72.7 | 4,921,901 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 41,640 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.91 per share. | 12 Aug 2024 | 41,640 | 142,267 (0%) | 0% | 13.9 | 579,212 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 34,530 | 34,530 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 12 Aug 2024 | 34,530 | 176,797 (0%) | 0% | 17.1 | 589,427 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 73.65 per share. | 12 Aug 2024 | 20,415 | 88,727 (0%) | 0% | 73.7 | 1,503,565 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 11,900 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.16 per share. | 12 Aug 2024 | 11,900 | 100,627 (0%) | 0% | 17.2 | 204,204 | Common Stock |
| Lamb Weston Holdings Inc | Michael Jared Smith | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.38 per share. | 06 Aug 2024 | 1,107 | 71,084 (0%) | 0% | 57.4 | 63,520 | Common Stock |
| PetIQ Inc - Ordinary Share... | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2024 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| PetIQ Inc - Ordinary Share... | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2024 | 50,000 | 120,331 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc - Ordinary Share... | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.44 per share. | 05 Aug 2024 | 22,523 | 97,808 (0%) | 0% | 21.4 | 482,893 | Class A Common Stock |
| Lamb Weston Holdings Inc | Michael Jared Smith | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.23 per share. | 29 Jul 2024 | 10,415 | 72,191 (0%) | 0% | 56.2 | 585,635 | Common Stock |
| Lamb Weston Holdings Inc | Michael Jared Smith | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 13,225 | 82,608 (0%) | 0% | 0 | Common Stock | |
| Church Dwight Co Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 760 | 780 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.05 per share. | 08 Jul 2024 | 730 | 88,727 (0%) | 0% | 70.1 | 51,137 | Common Stock |
| Ulta Beauty | Michael C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 452 | 2,380 (0%) | 0% | 0 | Common Stock | |
| Tutor Perini Corp | Michael Francis Smithson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 50,000 | 72,825 (0%) | 0% | - | Common Stock | |
| Tutor Perini Corp | Michael Francis Smithson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 28 May 2024 | 44,722 | 88,828 (0%) | 0% | 49.5 | 2,215,081 | Common Stock |
| Tutor Perini Corp | Michael Francis Smithson | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.50 per share. | 28 May 2024 | 26,975 | 45,850 (0%) | 0% | 21.5 | 579,963 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 14,810 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.67 per share. | 28 May 2024 | 14,810 | 133,550 (0%) | 0% | 13.7 | 202,453 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.16 per share. | 28 May 2024 | 10,000 | 111,579 (0%) | 0% | 16.2 | 161,600 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 7,000 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.07 per share. | 28 May 2024 | 7,000 | 101,579 (0%) | 0% | 16.1 | 112,490 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,691 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 28 May 2024 | 3,691 | 115,270 (0%) | 0% | 10.8 | 40,047 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,470 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.38 per share. | 28 May 2024 | 3,470 | 118,740 (0%) | 0% | 11.4 | 39,489 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 65,230 | 65,230 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 13,308 | 99,672 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 25.40 per share. | 13 May 2024 | 5,093 | 94,579 (0%) | 0% | 25.4 | 129,362 | Common Stock |
| Zebra Tech | Michael A. Smith | Director | Grant, award, or other acquisition of securities at price $ 316.50 per share. | 09 May 2024 | 696 | 9,865 (0%) | 0% | 316.5 | 220,284 | Class A Common Stock |
| PetIQ Inc - Ordinary Share... | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 6,250 | 6,250 | - | - | Restricted Stock Unit | |
| PetIQ Inc - Ordinary Share... | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 6,250 | 73,153 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc - Ordinary Share... | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.58 per share. | 07 May 2024 | 2,822 | 70,331 (0%) | 0% | 17.6 | 49,611 | Class A Common Stock |
| Teledyne Technologies Inc | Michael T. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 468 | 56,960 (0%) | 0% | 0 | Common Stock | |
| Danimer Scientific Inc | Michael Eric Smith | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2024 | 263,410 | 263,410 | - | - | Stock Appreciation Rights | |
| Danimer Scientific Inc | Michael Eric Smith | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2024 | 151,585 | 151,585 | - | - | Performance Stock Award | |
| ICC Holdings Inc | Michael R. Smith | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,100 | 3,100 | - | - | Restricted Stock Unit | |
| ICC Holdings Inc | Michael R. Smith | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Apr 2024 | 834 | 6,931 (0%) | 0% | 16 | 13,344 | Common Stock |
| ICC Holdings Inc | Michael R. Smith | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 834 | 0 | - | - | Restricted Stock Unit | |
| ICC Holdings Inc | Michael R. Smith | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Apr 2024 | 700 | 8,131 (0%) | 0% | 16 | 11,200 | Common Stock |